IQVIA™ Real-World Insights Bibliography

Lessons learned on enhanced passive safety surveillance of influenza vaccines.
Author(s): Khalife N., Almas M, Stam Morago, M, Negreiro F, Costa L, Projetto, S
Affiliations(s): 
Publication(s):  Pharmacoepidemiol & Drug Saf 2018;27(2):495
Document Type(s): Poster,
Countries: 
C:
Y:
Immunology and Vaccination,
2018
  L:
A:
English
  Add to report
 
 
Observational safety study of specific outcomes after trivalent cell culture seasonal influenza vaccination (Optaflu® ) among adults in THIN database of electronic UK primary healthcare records
Author(s): Hall GC, Davies PTG, Karim MY, Haag MDM & O'Leary C
Affiliations(s): Seqirus
Publication(s):  Pharmacoepidemiology and Drug Safety
Document Type(s): Article,
Countries: UK,
C:
Y:
Immunology and Vaccination,
2018
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Epidemiologic and economic burden of HPV diseases in Spain: implication of additional 5 types from the 9-valent vaccine.
Author(s): López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4, Perulero N4.
Affiliations(s): 1Medical Affairs, MSD, Madrid, Spain.22Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain.33Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain.4Health Economics and Outcomes Research, Real World Insights, IQVIA, Barcelona, Spain.
Publication(s):  Infect Agent Cancer. 2018 May 2;13:15.
Document Type(s): Article,
Countries: Spain,
Click here for the abstract
C:
Y:
Health economics, Immunology and Vaccination, Infectious disease, Oncology,
2018
  L:
A:
English
Burden of illness, clinical setting: Secondary care, Literature Review, Review, Survey research,
  Add to report
 
 
Predictors and diseasburden of ulcerative colitis progression in Sweden.
Author(s): Stålhammar J1,Hällström P1, Agreus L2, Beydogan H3, Arnheim Dahlström L3, Skup M4, Lee W-J4
Affiliations(s): 1 Uppsala University, Uppsala, Sweden 2 Karolinska Institutet, Stockholm, Sweden 3 QuintilesIMS, Stockholm, Sweden 4 AbbVie Inc., North Chicago, USA.
Publication(s):  UEG Barcelona September 2017
Document Type(s): Abstract,
Countries: Sweden,
C:
Y:
Immunology and Vaccination,
2017
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
Market share and switching dynamics between Etanercept and its biosimilar product in Sweden and Germany: a real-world preliminary analysis.
Author(s): Alten R1, Neregård P2, Jones HE3, Meng T4, Curiale C5, Singh E6, Lucchese L7, Gossen N8, Bergman GJ9, Miglio C7
Affiliations(s): 1 Shlosspark-Klinik Teaching Hospital of the Charité, Berlin, Germany 2 Pfizer, Sollentuna, Sweden 3 Pfizer inc., Collegeville, PA, USA 4 Pfizer Pharma GmbH, Berlin, Germany 5 Pfizer, Rome, Italy 6 Pfizer Inc., Collegeville, PA, USA 7 QuintilesIMS, London, UK 8 QuintilesIMS, Frankfurt, Germany 9 QuintilesIMS, Solna, Sweden
Publication(s):  ISPOR 20th Annual European Congress
Document Type(s): 
Countries: Germany, Sweden,
Click here for the abstract
C:
Y:
Immunology and Vaccination, Patient Registries & Real-World Study Methods, Rheumatology,
2017
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Compliance with vaccination against hepatitis A virus in Germany: a retrospective analysis
Author(s): Jacob L, Kostev K
Affiliations(s): 
Publication(s):  Int J Clin Pharmacol Ther. 2017 Jul 24. doi: 10.5414/CP202990. [Epub ahead of print]
Document Type(s): Article,
Countries: Germany,
C:
Y:
Immunology and Vaccination,
2017
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
Compliance with vaccination against tick-borne encephalitis virus in Germany
Author(s): Jacob L, Kostev K
Affiliations(s): 
Publication(s):  Clin Microbiol Infect. 2017 Jan 28. pii: S1198-743X(17)30045-9. doi: 10.1016/j.cmi.2017.01.012. [Epub ahead of print]
Document Type(s): Article,
Countries: Germany,
C:
Y:
Immunology and Vaccination,
2017
  L:
A:
English
  Add to report
 
 
Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model
Author(s): Gerlier L1, Hackett J2, Lawson R2, Dos Santos Mendes S3, Weil-Olivier C4, Schwehm M5, Eichner M6,7
Affiliations(s): 1 QuintilesIMS, Real-World Evidence Solutions, Zaventem, Belgium 2 AstraZeneca, Gaithersburg, MD, USA 3 AstraZeneca, Brussels, Belgium (Current affiliation: MSD, Brussels, Belgium) 4 Department of Pediatrics, University Paris VII, Paris, France 5 ExploSYS GmbH, Leinfelden-Echterdingen, Germany 6 Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany 7 Epimos GmbH, Dusslingen, Germany
Publication(s):  JHEOR 2017;5(1):89-108
Document Type(s): Article,
Countries: Australia, Belgium, Finland, France, Germany, Greece, Italy, Luxembourg, Netherlands, Poland, Portugal, Spain, Sweden, UK,
C:
Y:
Immunology and Vaccination, Infectious disease, Respiratory disease,
2017
  L:
A:
English
Epidemiological study, Public Health,
  Add to report
 
 
Epidemiologic and economic burden of HPV-related diseases in Spain: Potential benefit of adding 5 additional types in the nonavalent vaccine.
Author(s): López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4, Perulero N4
Affiliations(s): 1 Medical Affairs, Sanofi Pasteur MSD, Madrid, Spain 2 Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain 3 Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain 4 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain
Publication(s):  HPV2017 31st International papillomavirus conference, 2017, February 28 – March 4, Cape Town, South Africa
Document Type(s): Poster,
Countries: Spain,
Click here for the abstract
C:
Y:
Dermatology, Health economics, Immunology and Vaccination, Oncology,
2017
  L:
A:
English
Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Literature Review, Survey research,
  Add to report
 
 
Impacto económico de las enfermedades asociadas al VPH en España: beneficio potencial de la vacuna nonavalente frente a la tetravalente [Economic impact of HPV-associated diseases in Spain: potential benefit of nonvalorent versus tetravalent vaccine].
Author(s): López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4
Affiliations(s): 1 Medical Affairs, MSD, Madrid, Spain 2 Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain 3 Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain 4 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain
Publication(s):  XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España
Document Type(s): Poster,
Countries: Spain,
Click here for the abstract
C:
Y:
Dermatology, Health economics, Immunology and Vaccination, Oncology,
2017
  L:
A:
Spanish
Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review, Survey research,
  Add to report
 
 
 1 of 7 Next Page Last Page